Capecitabin "Zentiva"

DRUG2 trials

Sponsors

Enliven Therapeutics Inc., Glaxosmithkline Research & Development Limited

Conditions

Colorectal Cancer and Breast CancerMMRp/ MSS colon cancerSolid Tumors

Phase 1

A Phase 1a/1b Study of ELVN-002 Combined with Trastuzumab in Advanced Stage HER2+ Solid tumors, and ELVN-002 Combined with Trastuzumab and Chemotherapy in Advanced Stage HER2+ Colorectal Cancer and Breast Cancer

Active, not recruitingCTIS2023-509716-29-00

Enliven Therapeutics Inc.Colorectal Cancer and Breast Cancer, Solid Tumors

Start: 2024-09-23Target: 156Updated: 2025-11-24

Phase 2

A Phase 2, open label, randomized study of neoadjuvant dostarlimab plus CAPEOX versus CAPEOX in participants with previously untreated T4N0 or Stage III MMRp/ MSS colon cancer

RecruitingCTIS2024-513441-36-00

Glaxosmithkline Research & Development LimitedMMRp/ MSS colon cancer

Start: 2024-11-27Target: 170Updated: 2025-12-18